- Home
- GPRO vs BWAY Comparison
GPRO vs BWAY Comparison
Compare GPRO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- BWAY
- Stock Information
- Founded
- GPRO 2004
- BWAY 2003
- Country
- GPRO United States
- BWAY Israel
- Employees
- GPRO N/A
- BWAY N/A
- Industry
- GPRO Industrial Machinery/Components
- BWAY Medical/Dental Instruments
- Sector
- GPRO Consumer Discretionary
- BWAY Health Care
- Exchange
- GPRO Nasdaq
- BWAY Nasdaq
- Market Cap
- GPRO 193.5M
- BWAY 177.4M
- IPO Year
- GPRO 2014
- BWAY 2019
- Fundamental
- Price
- GPRO $1.05
- BWAY $10.66
- Analyst Decision
- GPRO Hold
- BWAY Strong Buy
- Analyst Count
- GPRO 1
- BWAY 3
- Target Price
- GPRO $1.50
- BWAY $13.17
- AVG Volume (30 Days)
- GPRO 1.6M
- BWAY 57.5K
- Earning Date
- GPRO 02-06-2025
- BWAY 03-05-2025
- Dividend Yield
- GPRO N/A
- BWAY N/A
- EPS Growth
- GPRO N/A
- BWAY N/A
- EPS
- GPRO N/A
- BWAY 0.04
- Revenue
- GPRO $896,011,000.00
- BWAY $38,631,000.00
- Revenue This Year
- GPRO N/A
- BWAY $388.82
- Revenue Next Year
- GPRO N/A
- BWAY $18.70
- P/E Ratio
- GPRO N/A
- BWAY $128.37
- Revenue Growth
- GPRO N/A
- BWAY 34.19
- 52 Week Low
- GPRO $0.89
- BWAY $4.61
- 52 Week High
- GPRO $3.03
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- GPRO 48.92
- BWAY 46.35
- Support Level
- GPRO $0.89
- BWAY $10.24
- Resistance Level
- GPRO $1.04
- BWAY $10.89
- Average True Range (ATR)
- GPRO 0.05
- BWAY 0.47
- MACD
- GPRO -0.00
- BWAY -0.04
- Stochastic Oscillator
- GPRO 68.76
- BWAY 10.34
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.